Main > INFECTIOUS DISEASES > IE. N. CABP>Treat.>PleuroMutilin>



IE. N. CABP>Treat.>PleuroMutilin>'s subsections
(*) CA Approval Date: 2020. 07.16
(*) EU CE Mark Date: 2020. 07.28
(*) USA Approval Date: 2019. 08.19
(*) USA Launch Date: 2019. 09.09
>Antibiotics IV & Oral
Company
Company CA
Generic Name
Patent>CA Patent Number
Patent>EU Patent Numbers
Patent>USA Patent Numbers
TM
TM Web-Site EU
TM Web-Site USA

IE. N. CABP>Treat.>PleuroMutilin>'s products
This section has no products